Nxera unveils proprietary pipeline targeting obesity and metabolic disorders

6th August 2025 Uncategorised 0

New oral GLP-1 agonist aims to reshape chronic weight management

More: Nxera unveils proprietary pipeline targeting obesity and metabolic disorders
Source: News